Aaron Weaver is a principal at Apeiron Investment Group, the family office of German entrepreneur and investor, Christian Angermayer. Christian has been founder of companies across a number of sectors, including biotech, where has founded Ribopharma (merged with Analylam), atai Life Sciences, Rejuveron Life Sciences and Cambrian Bio. The family office is an investor across biotech, crypto and fintech, deep tech, novel foods, space tech and other cutting edge tech domains. Aaron was part of the early team at atai life sciences, which brought the use of psychedelic medicines into mainstream mental healthcare and is also deeply involved in the business of longevity. Aaron coordinates the direct investment activities of the family office.